Ticker > Company >

Krsnaa Diagnostics share price

Krsnaa Diagnostics Ltd.

NSE: KRSNAA BSE: 543328 SECTOR: Hospital & Healthcare Services  131k   232   60

682.00
+5.20 (0.77%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 683.35

Today's Low

₹ 647.7

52 Week High

₹ 1041.8

52 Week Low

₹ 600.4

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

2202.16 Cr.

Enterprise Value

2308.92 Cr.

No. of Shares

3.23 Cr.

P/E

26.59

P/B

2.47

Face Value

₹ 5

Div. Yield

0.41 %

Book Value (TTM)

₹  276.65

CASH

53.03 Cr.

DEBT

159.79 Cr.

Promoter Holding

27.24 %

EPS (TTM)

₹  25.65

Sales Growth

27.14%

ROE

7.54 %

ROCE

10.1%

Profit Growth

-7.79 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year27.14%
3 Year14.17%
5 Year23.04%

Profit Growth

1 Year-7.79%
3 Year-31.84%
5 Year24.65%

ROE%

1 Year7.54%
3 Year12.49%
5 Year7.49%

ROCE %

1 Year10.1%
3 Year13.4%
5 Year-11.24%

Debt/Equity

0.1966

Price to Cash Flow

90.27

Interest Cover Ratio

5.3694

CFO/PAT (5 Yr. Avg.)

1.44892982931455

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 27.24 0.00
Dec 2024 27.24 0.00
Sep 2024 27.17 0.00
Jun 2024 27.17 0.00
Mar 2024 27.03 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -81.1324 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.44892982931455.

 Limitations

  • The company has shown a poor profit growth of -31.8388420688697% for the Past 3 years.
  • The company has shown a poor revenue growth of 14.1711630501172% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 159.33 163.16 178.72 165.16 174.65
Total Expenditure 116.06 120.18 126.24 117.26 121.35
Operating Profit 43.27 42.98 52.48 47.89 53.31
Other Income 4.34 7.32 4.6 9.29 4.46
Interest 7.32 5.3 6.39 6.13 6.75
Depreciation 18.12 21.47 22.2 22.69 21.8
Exceptional Items 0 0 0 0 0
Profit Before Tax 22.18 23.53 28.5 28.37 29.21
Tax 3.76 5.35 6.53 6.77 8.15
Profit After Tax 18.42 18.18 21.97 21.6 21.07
Adjusted EPS (Rs) 5.7 5.63 6.8 6.69 6.52

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 258.43 396.46 454.89 464.08 590.02
Total Expenditure 372.64 302.65 320.34 339.84 443.86
Operating Profit -114.21 93.81 134.55 124.25 146.16
Other Income 12.95 265.02 14.93 19.41 16.8
Interest 24.66 25.94 18.49 7.68 16.47
Depreciation 32.41 37.44 41.39 53.78 74.55
Exceptional Items 0 0 0 0 0
Profit Before Tax -158.33 295.45 89.6 82.19 71.95
Tax -46.38 110.52 18.9 18.68 13.38
Net Profit -111.95 184.93 70.7 63.51 58.56
Adjusted EPS (Rs.) -108.42 142.36 22.52 20.23 18.14

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 20.19 248.89 15.7 15.7 16.15
Total Reserves -217.16 -17.02 671.05 726.8 799.1
Borrowings 122.71 167.95 33.07 24.28 41.88
Other N/C liabilities 431.28 20.91 37.59 47.35 38.39
Current liabilities 180.8 188.55 119.64 95.25 276.05
Total Liabilities 537.81 609.28 877.06 909.38 1171.57
Assets
Net Block 275.1 308.51 385.69 470.68 647.16
Capital WIP 9.13 3.72 28.26 25.48 9.85
Intangible WIP 0 0 0 0 0
Investments 0.29 0.29 0.36 0.36 0.36
Loans & Advances 28.16 33.83 17.87 26.37 62.37
Other N/C Assets 11.51 10.04 109.11 162.75 29.43
Current Assets 213.63 252.89 335.77 223.75 422.41
Total Assets 537.81 609.28 877.06 909.38 1171.57
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -158.33 295.45 89.6 82.19 71.95
Adjustment 225.66 -198.74 49.2 44.79 69.9
Changes in Assets & Liabilities -19.32 29.62 -3.46 -38.37 -98.65
Tax Paid -10.2 -7.67 -6.63 -13.13 -18.8
Operating Cash Flow 37.81 118.66 128.71 75.48 24.39
Investing Cash Flow -76.65 -67.37 -241.1 -108.54 -128.88
Financing Cash Flow 5.78 20.03 176.04 -33.13 84.21
Net Cash Flow -33.06 71.32 63.65 -66.19 -20.27

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 27.03 27.17 27.17 27.24 27.24
krsna diagnostics (mumbai... 2.16 2.30 2.30 2.37 2.37
rajendra khivraj mutha 24.87 24.87 24.87 24.87 24.87
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 72.97 72.83 72.83 72.76 72.76
bandhan bse healthcare in... - - 1.34 1.25 1.32
hdfc life insurance compa... 1.93 2.06 2.06 2.06 2.06
k india opportunities fun... - 2.19 2.19 2.19 2.19
kirankumar prabhakar bhis... 1.52 1.57 1.20 1.23 1.10
phi capital trust - phi c... 15.44 15.44 15.44 15.44 15.44
tata mutual fund - tata s... 7.40 7.73 7.73 7.73 7.73
icici prudential pharma h... 2.73 2.73 2.15 - -
bandhan small cap fund - 1.33 - - -
aditya birla sun life ins... 1.36 - - - -
cybage software private l... 1.00 - - - -
k india opportunities fun... 2.19 - - - -
kitara piin 1104 1.26 - - - -

Annual Reports

Title Action
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018

Ratings & Research Reports

TYPE AGENCY ACTION
Credit CRISIL
Credit ICRA
Credit CRISIL
TYPE AGENCY ACTION
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER ACTION
Concall Q4FY24
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY23
Concall Q3FY22
Concall Q2FY22
Concall Q1FY24
Concall Q1FY23
TYPE QUARTER ACTION
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY23
Presentation Q4FY22
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY22
Presentation Q2FY24
Presentation Q2FY22

Company News

Krsnaa Diagnostics Stock Price Analysis and Quick Research Report. Is Krsnaa Diagnostics an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Krsnaa Diagnostics and its performance over the period of time. Krsnaa Diagnostics stock price today is Rs 677.6.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Krsnaa Diagnostics cash from the operating activity was Rs 24.394 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Krsnaa Diagnostics has a Debt to Equity ratio of 0.1966 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Krsnaa Diagnostics , the EPS growth was -10.3366 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Krsnaa Diagnostics has OPM of 24.772592069069 % which is a good sign for profitability.
     
  • ROE: Krsnaa Diagnostics have a poor ROE of 7.5433 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Krsnaa Diagnostics is Rs 677.6. One can use valuation calculators of ticker to know if Krsnaa Diagnostics share price is undervalued or overvalued.
Last Updated on:
Brief about Krsnaa Diagnostics
X